Home›Pediatrics› Depressive symptoms affect about one third of patients with childhood-onset lupus, with tool-dependent variation
Depressive symptoms affect about one third of patients with childhood-onset lupus, with tool-dependent variationOne in three children with lupus show signs of depression
Frontiers in MedicinePublished October 30, 2026DOI ↗Editorial oversight: Dr. Sofia Müller, MD · Lifespan & Whole-Person Care
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider depression screening in cSLE, but interpret positive screens cautiously given tool-dependent prevalence.
This meta-analysis examined the prevalence of screening-positive depressive symptoms in patients with childhood-onset systemic lupus erythematosus (cSLE), pooling data from 652 patients. The primary outcome was the prevalence of screening-positive depressive symptoms, with anxiety as a secondary outcome.
The pooled prevalence of depression was 32.6% (95% CI 24.5% to 41.8%). Estimates differed by screening instrument: 26% with the CDI tool (95% CI 0.18 to 0.34, P = 0.023) and 41% with the PHQ-9 tool (95% CI 0.20 to 0.63).
The authors report moderate between-study heterogeneity (I2 = 73.66%), which limits confidence in a single pooled estimate. Safety data, follow-up duration, and funding or conflicts were not reported. The analysis reports prevalence of symptoms on screening tools, not clinical diagnosis of depression, and this distinction should be kept in mind when interpreting the estimates.
Practice relevance was not reported. The findings suggest that depressive symptoms are common on screening in cSLE, but the wide confidence intervals and tool-dependent variation mean the estimates should be viewed as approximate. Clinicians may consider screening, while recognizing that a positive screen is not equivalent to a diagnosis and that the evidence does not establish causality or optimal screening strategies.
How this fits prior evidence
This meta-analysis extends prior coverage of mental health in chronic disease, including a narrative review linking adolescent idiopathic scoliosis to anxiety and depression via stress, pain, and body image pathways, by providing a pooled prevalence estimate specific to childhood-onset SLE. It also aligns with prior coverage noting that immune-mediated comorbidities are common in MS but causality remains uncertain, as the cSLE data are cross-sectional prevalence estimates without causal inference. Unlike prior coverage of digital phenotyping for real-time mental health monitoring, this analysis addresses screening prevalence rather than monitoring technology. The tool-dependent variation (26% with CDI vs 41% with PHQ-9) underscores the need to interpret screening estimates in light of the instrument used.
Living with a chronic illness like systemic lupus erythematosus (SLE) is physically exhausting. For children diagnosed with the condition early in life, the mental toll can be just as heavy as the physical symptoms. New data helps us understand how common these mental health struggles actually are in this specific group.
Researchers looked at 652 patients with childhood-onset lupus to see how many showed signs of depression. They found that about 32.6% of these children showed symptoms of depression. Depending on the specific screening tool used, the numbers varied slightly, with some tests showing 26% and others showing 41% of patients experiencing these symptoms.
It is important to remember that these results track the presence of symptoms rather than a formal clinical diagnosis of depression. While the data shows a significant overlap between lupus and mental health struggles, the differences in how studies were conducted mean the results should be viewed as a broad look at the patient population.
What this means for you:
About 32.6% of children with childhood-onset lupus show symptoms of depression.
Common questions
How many children with lupus show signs of depression?
The study found that 32.6% of the 652 patients with childhood-onset systemic lupus erythematosus showed symptoms of depression. Different screening tools showed slightly different results, with some tools finding 26% and others finding 41% of patients showing symptoms.
Does this mean the children have a clinical diagnosis of depression?
No, the study specifically measured the prevalence of screening-positive depressive symptoms. This means the data shows that children are experiencing symptoms of depression, but it does not provide a formal clinical diagnosis for each individual.
ObjectiveChildhood-onset systemic lupus erythematosus (cSLE) is frequently associated with psychological symptoms, particularly depression. However, there remains a lack of quantitative evidence regarding the prevalence of screening-positive depressive symptoms based on the currently available evidence. In this context, we conducted a systematic review and meta-analysis addressing this important issue.MethodsThree medical databases, including PubMed, Embase, Cochrane Library were utilized in this study. We included studies that reported on cSLE patients experiencing depression for a meta-analysis, without publication language restrictions. Anxiety were included as secondary outcomes. STATA software were employed to synthesize the results as well as to assess heterogeneity and publication bias.ResultsTotally 12 eligible studies encompassing 652 patients were incorporated into this meta-analysis. Each of the publications included exhibited commendable methodological rigor, with Newcastle-Ottawa scores no less than 6. The pooled prevalence was [32.6%] (95% CI: [24.5%–41.8%]). Between-study heterogeneity was moderate (I2 = [73.66%]; τ2 = [0.26] on the logit scale). Subsequent subgroup analysis indicated that the prevalence of depression varied according to the different screening tools used: it was found to be 26% with CDI (95% CI: 0.18–0.34, P = 0.023, I2 = 61.8%), 41% with PHQ-9 (95% CI: 0.20–0.63, P
